B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MAPK1 (ERK2) activation

REACTOME PATHWAY
Reactome: R-HSA-1124115 genes43 compounds

The MAPK1 (ERK2) activation pathway (Reactome ID: R-HSA-112411) involves 5 genes and is affected by 43 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

IL6JAK2MAP2K2MAPK1TYK2

Compounds Affecting MAPK1 (ERK2) activation

#CompoundTargets HitStudies
1pd980597
2sp600125117
3trametinib296
4Dasatinib299
5Axitinib298
6plumbagin [Supplementary Concept]300
7tyrphostin ag 14784
8alsterpaullone12
9kenpaullone8
10Clotrimazole296
11fisetin78
12Progesterone299
132-Chloroadenosine 2-Chloroadenosine.300
14Benzalkonium Compounds299
15Calcimycin216
16daph2
17Diphenhydramine14
18ha10044
19isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
20Lithocholic Acid300
21Loratadine296
22Sorafenib300
23trequinsin hydrochloride1
24withaferin300
25Azauridine300
26Cladribine297
27Methylene Blue200
282-Methoxyestradiol300
29Astemizole Antihistamine drug now withdrawn from280
30Azathioprine300
31Calcitriol300
32Camptothecin300
33Cytarabine297
34dihydrorotenone13
35Podophyllotoxin14
36streptonigrin299
37Trifluridine295
38Tripterygium300
39Crizotinib298
40Methotrexate289
41pictilisib25
42Vemurafenib298
43Prednisolone1,000

About the MAPK1 (ERK2) activation Pathway

The MAPK1 (ERK2) activation pathway is catalogued in Reactome (ID: R-HSA-112411) and involves 5 genes. In the BiohacksAI corpus, 43 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include IL6, JAK2, MAP2K2, MAPK1, TYK2.